Competing policy efforts to lower drug prices could muddy the waters of drug pricing and leave patients unable to afford ...

The name “340B” comes from the section of the U.S. Public Health Service Act of 1992 that requires pharmaceutical ...

The 340B ACCESS Act ensures savings go where they belong: to patients and communities.Protect Delaware’s most vulnerable.

Hospitals across Michigan are exploiting a little-known federal program to squeeze millions of dollars out of the state's ...

AHA sues block 340B changes that impose costs on safety-net hospitals and risk care access in rural and underserved communities.

In this Leadership Dialogue conversation, Tina Freese Decker, president and CEO of Corewell Health and 2025 AHA board chair, joins Aimee Kuhlman, vice president of advocacy grassroots and government ...

Groceries, medications, new shoes, electric bills: many Central Valley families face impossible choices. Prescription drugs should not be on that list.

AHA Board Chair Tina Freese Decker talks with AHA VP Aimee Kuhlman and Monument Health CEO Paulette Davidson about the benefits of the 340B program.

The Orphan Drug Act has catalyzed innovation in rare disease treatments, but the law’s shortcomings — particularly around ...

Hospital groups warn the 340B rebate pilot would force safety net providers to front tens of millions of dollars for drugs ...

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...

Key Takeaways - CMS launches Drug Acquisition Cost Survey beginning Jan. 1, 2026. OPPS hospitals must submit NDC-level pricing data for ...